Stem cell therapy for corneal damage is pioneering a new era in ocular medicine, providing hope for patients suffering from vision loss due to severe corneal injuries.Recent clinical trials at Mass Eye and Ear have showcased the success of cultivated autologous limbal epithelial cells (CALEC) in restoring the cornea’s surface for individuals who previously had limited options for treatment.